Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
University of North Carolina at Chapel Hill
Research
Dual approach puts the sting back in STING therapy
Researchers elucidated a mechanism that could explain why STING therapies falter, while introducing a dual therapy to improve their efficacy.
Helen Floersh
Oct 7, 2022 12:29pm
Producing faster CAR-T cell therapy with an implant
Mar 28, 2022 5:21pm
COVID-19: Repurposing antiviral, anticancer discoveries
Mar 30, 2020 1:59pm
Improving CAR-T therapy for cancer by regulating 2 proteins
Jan 31, 2020 8:45am
T-cell therapy for HIV proves safe in small study
Sep 21, 2018 11:00am
New discoveries in cancer and male contraception—News of Note
Apr 23, 2018 12:06pm
